Antibody licensing

 

At BioPorto Diagnostics we are always interested in expanding our AntibodyShop® antibody portfolio. If you have any monoclonal antibodies, which you would like to commercialize and make available to researchers all around the world, we would be very happy to hear from you. We have a long, successful track record of in-licensing antibodies, which has given us efficient licensing procedures combined with effective process for commercialization.

  • we can offer to license your unique antibody clones and get royalties coming back to you
  • we have a state-of-the-art hybridoma cell culturing facility, which will ensure that only the best quality product is marketed from your hybridomas 
BioPorto´s current product portfolio consists of unique antibodies within the research area of coagulation, complement cascade, peptide hormones and kidney diseases. BioPorto seeks to strengthen our product portfolio within these areas as well as building product groups within other research and clinical spaces.

Contact

Please contact Global Product Manager Imrana Shahzada: ims@bioporto.com.